Oramed Pharmaceuticals, Inc. (ORMP)

3.42 -0.31 (-8.31%) USD  |  NASDAQ  |  Feb 26, 16:00
3.42 0.00 (0.00%) After-Hours: 18:41
More

Oramed Pharmaceuticals Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for ORMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Lifeward Ltd. Upgrade
Bristol Myers Squibb Co. Upgrade
Merck & Co., Inc. Upgrade
Instil Bio, Inc. Upgrade
Moderna, Inc. Upgrade